INTRODUCING IPS: A PROGNOSTIC BIOMARKER FOR PATIENTS ON ICI THERAPY /// LEARN MORE INTRODUCING IPS: A PROGNOSTIC BIOMARKER FOR PATIENTS ON ICI THERAPY /// LEARN MORE
September 17 — 18, 2024 PHILADELPHIA, PA

Exhibit Booth #522
Conference Session

BioTechX USA 2024

Tempus is advancing precision medicine through the practical application of artificial intelligence in healthcare. We are pleased to attend the 2024 congress of BioTechX USA and present how Tempus leverages AI for RWE generation to support drug development.

Schedule a meeting with us
Conference Session
September 17, 2024
live session
Time
12:05pm–12:25pm ET

Location
Pennsylvania Convention Center
1101 Arch St, Philadelphia, PA 19107

Session Track
Breakout in the 'Real World Evidence' track
Presenter
Kate Sasser, PhD
Chief Scientific Officer (Tempus)

Harnessing AI with Multimodal Data to Transform Drug Development

Discover how layering ML and AI on multimodal data can drive insights and propel various stages of drug discovery and development. Dive into Tempus' expertise in leveraging real-world data for novel target discovery, clinical trial optimization, translational research, and evidence generation. Join us to explore how AI is rapidly evolving to deliver value in advancing precision medicine and enhancing patient outcomes.

Read more

Schedule a meeting with us

We'll be in touch shortly.